scispace - formally typeset
H

Hyo Jung Kim

Researcher at Gyeongsang National University

Publications -  21
Citations -  647

Hyo Jung Kim is an academic researcher from Gyeongsang National University. The author has contributed to research in topics: Aldose reductase & Peroxisome proliferator-activated receptor. The author has an hindex of 15, co-authored 20 publications receiving 607 citations.

Papers
More filters
Journal ArticleDOI

Transforming Growth Factor-β1 Is a Molecular Target for the Peroxisome Proliferator-Activated Receptor δ

TL;DR: The presence of a novel TGF-&bgr;1–mediated pathway in the antiinflammatory activities of PPAR&dgr; is demonstrated, whereas the expression of proinflammatory genes including monocyte chemoattractant protein-1 was significantly attenuated in the thoracic aorta.
Journal ArticleDOI

Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes.

TL;DR: Observations indicated that substrate-induced induction of AR by MG during hyperglycemic conditions may hinder vascular remodeling and accelerate the development of vascular lesions in diabetes.
Journal ArticleDOI

Peroxisome Proliferator-Activated Receptor δ Regulates Extracellular Matrix and Apoptosis of Vascular Smooth Muscle Cells Through the Activation of Transforming Growth Factor-β1/Smad3

TL;DR: It is demonstrated that peroxisome proliferator-activated receptor (PPAR)&dgr; regulates extracellular matrix synthesis and degradation through transforming growth factor-β1 and its effector, Smad3, and suggested that PPAR-induced upregulation of extraceocytes exerts an antiapoptotic effect, thereby maintaining the stability of atherosclerotic plaques.
Journal ArticleDOI

Ran suppresses paclitaxel-induced apoptosis in human glioblastoma cells

TL;DR: Results suggest that Ran suppresses paclitaxel-induced cell death through the downregulation of JNK-mediated signal pathways.